TELFAST Side Effects

6999941-0 | Liver Disorder, Spleen Disorder
on Sep 16, 2010 Male patient from GERMANY , 44 years of age, weighting 324.1 lb, was treated with Telfast (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, spleen disorder. Telfast dosage: . During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), CHOLESTEROL AND TRIGLYCERIDE REDUCERS (View Cholesterol- And Triglyceride Reducers Review and Cholesterol- And Triglyceride Reducers Label ).

6817869-3 | Tetany, Tremor
Patient was taking Telfast (View Usage). Patient had the following side effects: tetany, tremor on Jun 29, 2010 from GERMANY Additional patient health information: Female patient , 15 years of age, weighting 136.7 lb, . Telfast dosage: . During the same period patient was treated with VIANI (2 X 1 Puff) (View Viani Review and Viani Label ).

6786125-4 | Hyperventilation, Off Label Use, Tremor
Adverse event was reported on Jun 18, 2010 by a Female patient taking Telfast (View Usage) (Dosage: ) was diagnosed with asthma (What is asthma?) and. Location: GERMANY , 15 years of age, After Telfast was administered, patient had the following side effects: hyperventilation, off label use, tremor. During the same period patient was treated with VIANI (View Viani Review and Viani Label ).

6743491-3 | Lymphadenopathy, Rash Maculo-papular, Toxic Skin Eruption
on May 18, 2010 Male patient from FRANCE , 63 years of age, was treated with Telfast (View Usage). Patient experienced the following unwanted or unexpected effects: lymphadenopathy, rash maculo-papular, toxic skin eruption. Telfast dosage: . During the same period patient was treated with ATARAX (View Atarax Review and Atarax Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), IBUPROFENE (View Ibuprofene Review and Ibuprofene Label ), MIZOLLEN (View Mizollen Review and Mizollen Label ). Patient was hospitalized.


6717282-3 | Anaphylactic Shock, Hypotension, Rash, Syncope, Urticaria
on May 02, 2010 Female patient from ISRAEL , 72 years of age, was treated with Telfast (View Usage). Patient had the following side effects: anaphylactic shock, hypotension, rash (What is rash?), syncope, urticaria. Telfast dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TRITACE (View Tritace Review and Tritace Label ), NORMITEN (View Normiten Review and Normiten Label ).

6686775-X | Lymphadenopathy, Rash Maculo-papular, Toxic Skin Eruption
Patient was taking Telfast (View Usage). After Telfast was administered, patient had the following side effects: lymphadenopathy, rash maculo-papular, toxic skin eruption on Apr 13, 2010 from FRANCE Additional patient health information: Male patient , 63 years of age, . Telfast dosage: . During the same period patient was treated with ATARAX (View Atarax Review and Atarax Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), IBUPROFENE (View Ibuprofene Review and Ibuprofene Label ), MIZOLLEN (View Mizollen Review and Mizollen Label ). Patient was hospitalized.

6590242-1 | Circulatory Collapse
Adverse event was reported on Feb 15, 2010 by a Female patient taking Telfast (View Usage) (Dosage: ) . Location: GERMANY , 50 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: circulatory collapse.

6509575-X | Arrhythmia, Syncope
on Dec 10, 2009 Female patient from GERMANY , 40 years of age, was treated with Telfast (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), syncope. Telfast dosage: .

6080827-3 | Toxic Skin Eruption
on Feb 06, 2009 Male patient from FRANCE , 53 years of age, was diagnosed with hypersensitivity, psychotic disorder (What is psychotic disorder?), hypothyroidism, epilepsy (What is epilepsy?), insomnia, constipation (What is constipation?), abnormal behaviour and was treated with Telfast (View Usage). After Telfast was administered, patient had the following side effects: toxic skin eruption. Telfast dosage: . During the same period patient was treated with TERCIAN (View Tercian Review and Tercian Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), KEPPRA (View Keppra Review and Keppra Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), ATARAX (View Atarax Review and Atarax Label ), NEULEPTIL (View Neuleptil Review and Neuleptil Label ), NULYTELY (View Nulytely Review and Nulytely Label ), TEGRETOL (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

5063521-7 | Chest Pain, Palpitations
Patient was taking Telfast (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), palpitations on Jul 18, 2006 from Additional patient health information: Female patient , 60 years of age, was diagnosed with seasonal allergy, angina pectoris, palpitations and. Telfast dosage: . During the same period patient was treated with VERAPAMIL (View Verapamil Review and Verapamil Label ).

4995059-7 | Agranulocytosis, Erysipelas, Mouth Ulceration, Pyrexia
Adverse event was reported on Apr 26, 2006 by a Male patient taking Telfast (View Usage) (Dosage: ) was diagnosed with pruritus and. Location: , 84 years of age, Patient had the following side effects: agranulocytosis, erysipelas, mouth ulceration, pyrexia. During the same period patient was treated with MONICOR LP (View Monicor Lp Review and Monicor Lp Label ), OMIX (View Omix Review and Omix Label ). Patient was hospitalized.

4866130-5 | Electrocardiogram Qt Prolonged, Respiratory Tract Infection, Supraventricular Tachycardia
on Nov 30, 2005 Male patient from NETHERLANDS , 14 years of age, was diagnosed with hypersensitivity, respiratory tract infection and was treated with Telfast (View Usage). After Telfast was administered, patient had the following side effects: electrocardiogram qt prolonged, respiratory tract infection, supraventricular tachycardia. Telfast dosage: . During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), SERETIDE (Dose: 1 Inhalation) (View Seretide Review and Seretide Label ), FLIXONASE (Dose: 1 Inhalation Both Nostrils) (View Flixonase Review and Flixonase Label ). Patient was hospitalized.

4850648-5 | Tachycardia, Ventricular Arrhythmia
on Nov 30, 2005 Male patient from NETHERLANDS , 15 years of age, was diagnosed with asthma (What is asthma?) and was treated with Telfast (View Usage). Patient experienced the following unwanted or unexpected effects: tachycardia, ventricular arrhythmia. Telfast dosage: . During the same period patient was treated with FLUTICASONE (View Fluticasone Review and Fluticasone Label ), SALMETEROL / FLUTICASONE (View Salmeterol / Fluticasone Review and Salmeterol / Fluticasone Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

4845898-8 | Tachycardia, Ventricular Arrhythmia
Patient was taking Telfast (View Usage). Patient had the following side effects: tachycardia, ventricular arrhythmia on Nov 30, 2005 from NETHERLANDS Additional patient health information: Male patient , 15 years of age, was diagnosed with asthma (What is asthma?) and. Telfast dosage: . During the same period patient was treated with FLUTICASONE (View Fluticasone Review and Fluticasone Label ), SALMETEROL / FLUTICASONE (View Salmeterol / Fluticasone Review and Salmeterol / Fluticasone Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

4835683-5 | Disorientation, Somnolence
Adverse event was reported on Nov 21, 2005 by a Male patient taking Telfast (View Usage) (Dosage: ) was diagnosed with rhinitis allergic and. Location: CROATIA (local name: Hrvatska) , 32 years of age, After Telfast was administered, patient had the following side effects: disorientation, somnolence.

4834111-3 | Extrasystoles, Tachycardia
on Jun 23, 2005 Female patient from UNITED KINGDOM , 43 years of age, weighting 164.2 lb, was diagnosed with seasonal allergy and was treated with Telfast (View Usage). Patient experienced the following unwanted or unexpected effects: extrasystoles, tachycardia. Telfast dosage: Dose: Unk. During the same period patient was treated with NEOCLARITYN (View Neoclarityn Review and Neoclarityn Label ), TRILUDAN (View Triludan Review and Triludan Label ).

4794486-0 | Arrhythmia
on Sep 21, 2005 Female patient from , 53 years of age, was diagnosed with swelling face and was treated with Telfast (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?). Telfast dosage: Dose: 1 Dose Form. During the same period patient was treated with DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), COMBIVENT (View Combivent Review and Combivent Label ), FLIXONASE (View Flixonase Review and Flixonase Label ), ISTIN (View Istin Review and Istin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PROTIUM (View Protium Review and Protium Label ), SERETIDE 250 (View Seretide 250 Review and Seretide 250 Label ).

4757807-0 | Hypertension
Patient was taking Telfast (View Usage). After Telfast was administered, patient had the following side effects: hypertension on Jul 08, 2005 from NETHERLANDS Additional patient health information: Female patient , 51 years of age, was diagnosed with multiple allergies, diaphragmatic hernia and. Telfast dosage: . During the same period patient was treated with LOSEC (View Losec Review and Losec Label ).

4753537-X | Anaphylactic Shock, Disorientation, Paraesthesia, Pruritus, Throat Tightness
Adverse event was reported on Aug 19, 2005 by a Female patient taking Telfast (View Usage) (Dosage: ) was diagnosed with hypersensitivity, depression (What is depression?), ulcer (What is ulcer?) and. Location: DENMARK , 53 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, disorientation, paraesthesia, pruritus, throat tightness. During the same period patient was treated with COMBAR (View Combar Review and Combar Label ), SPIRIX (View Spirix Review and Spirix Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SANTAX (View Santax Review and Santax Label ). Patient was hospitalized.

4748083-3 | Hypertension
on Jul 08, 2005 Female patient from NETHERLANDS , 51 years of age, was treated with Telfast (View Usage). Patient had the following side effects: hypertension. Telfast dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ).

4744997-9 | Neutropenia
on Jul 28, 2005 Male patient from AUSTRALIA , 81 years of age, was treated with Telfast (View Usage). After Telfast was administered, patient had the following side effects: neutropenia. Telfast dosage: . During the same period patient was treated with TAZAC (View Tazac Review and Tazac Label ).

4744996-7 | Convulsion
Patient was taking Telfast (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion on Jul 27, 2005 from Additional patient health information: Male patient , 36 years of age, was diagnosed with rhinitis seasonal and. Telfast dosage: . Patient was hospitalized.

4716038-0 | Extrasystoles, Tachycardia
Adverse event was reported on Jun 23, 2005 by a Female patient taking Telfast (View Usage) (Dosage: Dose: Unk) was diagnosed with seasonal allergy and. Location: UNITED KINGDOM , 43 years of age, weighting 164.2 lb, Patient had the following side effects: extrasystoles, tachycardia. During the same period patient was treated with NEOCLARITYN (View Neoclarityn Review and Neoclarityn Label ), TRILUDAN (View Triludan Review and Triludan Label ).

4716033-1 | Hypertension
on Jul 08, 2005 Female patient from NETHERLANDS , 51 years of age, was treated with Telfast (View Usage). After Telfast was administered, patient had the following side effects: hypertension. Telfast dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ).

4716032-X | Hyperglycaemia
on Jul 08, 2005 Female patient from UNITED KINGDOM , 34 years of age, was diagnosed with blood pressure (What is blood pressure?), diabetes mellitus and was treated with Telfast (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia. Telfast dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ANTIINFLAMMATORY/ANTIRHEUMATIC PRODUCTS (View Antiinflammatory/antirheumatic Products Review and Antiinflammatory/antirheumatic Products Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), LEVEMIR (View Levemir Review and Levemir Label ).

4712121-4 | Eosinophilia, Hepatomegaly, Lymphadenopathy, Nephritis Interstitial, Pyrexia, Stevens-johnson Syndrome
Patient was taking Telfast (View Usage). Patient had the following side effects: eosinophilia, hepatomegaly, lymphadenopathy, nephritis interstitial, pyrexia, stevens-johnson syndrome on Jun 28, 2005 from Additional patient health information: Male patient , 58 years of age, . Telfast dosage: . During the same period patient was treated with COLCHIMAX (View Colchimax Review and Colchimax Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TAREG (View Tareg Review and Tareg Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), FLUDEX (View Fludex Review and Fludex Label ).

4704302-0 | Tachycardia
Adverse event was reported on Jun 23, 2005 by a Female patient taking Telfast (View Usage) (Dosage: Dose: Unk) . Location: , 43 years of age, After Telfast was administered, patient had the following side effects: tachycardia. During the same period patient was treated with TRILUDAN (View Triludan Review and Triludan Label ).

4693132-4 | Supraventricular Tachycardia
on Jun 08, 2005 Female patient from , 32 years of age, was treated with Telfast (View Usage). Patient experienced the following unwanted or unexpected effects: supraventricular tachycardia. Telfast dosage: .

4622343-9 | Arthralgia, Myalgia
on Mar 21, 2005 Male patient from , 36 years of age, weighting 165.3 lb, was diagnosed with rash pruritic, acarodermatitis and was treated with Telfast (View Usage). Patient had the following side effects: arthralgia, myalgia. Telfast dosage: . During the same period patient was treated with PERMETHRIN (View Permethrin Review and Permethrin Label ).

4571547-2 | Blood Pressure Decreased, Dizziness, Hyperhidrosis, Hypersensitivity, Nausea, Tachycardia, Tremor
Patient was taking Telfast (View Usage). After Telfast was administered, patient had the following side effects: blood pressure decreased, dizziness (What is dizziness?), hyperhidrosis, hypersensitivity, nausea (What is nausea?), tachycardia, tremor on Jan 11, 2005 from Additional patient health information: Female patient , 32 years of age, weighting 191.8 lb, was diagnosed with conjunctivitis allergic, sleep disorder (What is sleep disorder?), tension and. Telfast dosage: . During the same period patient was treated with OPIPRAMOL (View Opipramol Review and Opipramol Label ).

4556510-X | Hepatotoxicity
Adverse event was reported on Oct 06, 2004 by a Female patient taking Telfast (View Usage) (Dosage: ) was diagnosed with urticaria, diabetes mellitus insulin-dependent, hypertension and. Location: , 40 years of age, Patient experienced the following unwanted or unexpected effects: hepatotoxicity. During the same period patient was treated with CIMETIDINE (Dose: Unk) (View Cimetidine Review and Cimetidine Label ), DESALEX (View Desalex Review and Desalex Label ), XYZAL (View Xyzal Review and Xyzal Label ), INSULIN (View Insulin Review and Insulin Label ), APROVEL (View Aprovel Review and Aprovel Label ), LASIX (View Lasix Review and Lasix Label ), ACTRAPID (View Actrapid Review and Actrapid Label ).

4551104-4 | Blood Pressure Decreased, Dizziness, Hyperhidrosis, Nausea, Tachycardia, Tremor
on Jan 11, 2005 Female patient from , 32 years of age, weighting 191.8 lb, was diagnosed with conjunctivitis allergic, tension and was treated with Telfast (View Usage). Patient had the following side effects: blood pressure decreased, dizziness (What is dizziness?), hyperhidrosis, nausea (What is nausea?), tachycardia, tremor. Telfast dosage: . During the same period patient was treated with OPIPRAMOL (View Opipramol Review and Opipramol Label ).